8 July 2024
TargetMol Inhibitors & Agonists: make your research faster and easier
TargetMol® offers 20,000+ inhibitor & agonists, widely applied in key research areas like cancer, diabetes, endocrine, nervous system, and metabolism.
TargetMol Chemicals Inc. is headquartered in the Greater Boston area, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 50+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and inhibitors & agonists.
Advantages of TargetMol
- High Coverage
Our inhibitors & agonists encompass over 3000 subtypes, 480+ receptors and 25+ signaling pathways and 200+ new compounds are added monthly. - Quality Control
NMR validates the accurate structures and HPLC/LC-MS varifies high purity. - Cost Effectiveness
TargetMol provides high-quality inhibitor & agonist products at a competitive prices. - Global Logistics
Global logistics ensures our fast delivery (1-2 days for in-stock products).
Hot selling inhibitors & agonists（target-based)
| PI3k/Akt/mTOR Signaling |
| RNA-3236 (T5993) |
| Rapamycin (T1537) |
| Salidroside (T2717) |
| Alpelisib (T1921) |
| MK-2206 dihydrochloride (T1952) |
| Angiogenesis |
| Lenvatinib (T0520) |
| Orelabrutinib (T12317) |
| Pexidartinib (T2115) |
| Crenolanib (T2677) |
| Amuvatinib (T2516) |
| Proteases/Proteasome |
| GK921 (T3968) |
| Leupeptin Hemisulfate (T6564) |
| Z-IETD-FMK (T7019) |
| Azvudine (T14489) |
| Z-YVAD-FMK (TP1466) |
| Stem Cells |
| RKI-1447 (T1898) |
| XAV-939 (T1878) |
| CHIR-99021 (T2310) |
| Verteporfin (T3112) |
| Y-27632 dihydrochloride (T1725) |
| Cell Cycle/Checkpoint |
| Adavosertib (T2077) |
| Palbociclib (T1785) |
| PF-06873600 (T8463) |
| COH29 (T3157) |
| Abemaciclib (T2381) |
| DNA Damage/DNA Repair |
| Bleomycin Sulfate (T6116) |
| Branaplam (T4641) |
| Ceralasertib (T3338) |
| Cisplatin (T1564) |
| Oxaliplatin (T0164) |
Direct contact technical support
Find products for your research